Cibc Asset Management Inc Abb Vie Inc. Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 362,342 shares of ABBV stock, worth $61.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

362,342

Previous 342,205 5.88%

Holding current value

$61.8 Million

Previous $58.7 Million 21.91%

% of portfolio

0.25%

Previous 0.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$163.84 - $199.33 $3.3 Million - $4.01 Million	20,137 Added 5.88%	362,342 $71.6 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $1.69 Million - $1.97 Million	-10,903 Reduced 3.09%	342,205 $58.7 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $419,847 - $478,376	-2,627 Reduced 0.74%	353,108 $64.3 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $1.95 Million - $2.19 Million	-14,138 Reduced 3.82%	355,735 $55.1 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $904,671 - $1.05 Million	-6,772 Reduced 1.8%	369,873 $55.1 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $1.48 Million - $1.84 Million	-11,132 Reduced 2.87%	376,645 $50.7 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $338,242 - $389,537	2,339 Added 0.61%	387,777 $61.8 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $376,064 - $451,000	-2,719 Reduced 0.7%	385,438 $62.3 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $11.6 Million - $13.3 Million	86,255 Added 28.57%	388,157 $52.1 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $763,240 - $970,328	5,546 Added 1.87%	301,902 $46.2 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $10.8 Million - $13.4 Million	82,023 Added 38.27%	296,356 $48 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $411,456 - $520,611	3,830 Added 1.82%	214,333 $29 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $384,316 - $436,257	3,612 Added 1.75%	210,503 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $624,105 - $695,289	5,932 Added 2.95%	206,891 $23.3 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $722,135 - $794,984	-7,059 Reduced 3.39%	200,959 $21.7 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $31,310 - $42,272	-389 Reduced 0.19%	208,018 $22.3 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $982,209 - $1.15 Million	-11,433 Reduced 5.2%	208,407 $18.3 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $312,189 - $417,755	4,255 Added 1.97%	219,840 $21.6 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $979,110 - $1.48 Million	-15,180 Reduced 6.58%	215,585 $16.4 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1.64 Million - $2.05 Million	-22,751 Reduced 8.97%	230,765 $20.4 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $285,425 - $343,163	4,532 Added 1.82%	253,516 $19.2 Million
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $1.33 Million - $1.7 Million	-20,200 Reduced 7.5%	248,984 $18.1 Million
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $7.1 Million - $8.36 Million	92,058 Added 51.97%	269,184 $21.7 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.35 Million - $1.67 Million	17,390 Added 10.89%	177,126 $16.3 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $543,595 - $604,307	6,114 Added 3.98%	159,736 $15.1 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $39,323 - $46,528	-438 Reduced 0.28%	153,622 $14.2 Million
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $2.5 Million - $3.35 Million	-27,186 Reduced 15.0%	154,060 $14.6 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $5.58 Million - $6.12 Million	-62,297 Reduced 25.58%	181,246 $17.5 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $17 Million - $21.7 Million	243,543	243,543 $21.6 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Abb Vie Inc. Transaction History